Klebsiella pneumoniae carbapenemase (KPC) is the most prevalent Ambler class A serine carbapenemase among Enterobacteriaceae worldwide. It accounts for the highest proportion of carbapenemases in carbapenem-resistant Klebsiella pneumoniae (CRKP) in China, with a detection rate exceeding 70%. KPC-producing K. pneumoniae is currently a high-priority, high-risk pathogen for healthcare-associated infection control, as it offers limited therapeutic options and is associated with poor patient outcomes, necessitating strict isolation and infection prevention measures.

AccuSift offers high-performance monoclonal antibody pairs against Klebsiella pneumoniae carbapenemase (KPC). Designed for IVD kit development (lateral flow, chemiluminescence, ELISA, POCT), these antibodies deliver excellent batch-to-batch consistency, high affinity, and high specificity to enable rapid detection.

Source: Mouse

Purity: ≥90%

Recommended pair: (Coating) / (Conjugate)

Storage: Long-term: ≤ –20 °C; Short-term: 2–8 °C. Shipped on ice packs.